The bill, H.B. No. 3176, proposes to amend the Health and Safety Code of Texas by adding a new section, 431.0215, which specifically addresses the manufacture, sale, and distribution of products developed using messenger ribonucleic acid (mRNA) material for the prevention or treatment of communicable diseases. The bill defines "mRNA material" as a substance that introduces mRNA corresponding to a viral protein and establishes that it is prohibited for any person to manufacture, sell, or distribute such products.

This legislation aims to regulate the use of mRNA technology in health-related products, reflecting growing concerns about the safety and efficacy of these treatments. The new provisions will take effect on September 1, 2025, allowing time for stakeholders to adjust to the new legal framework surrounding mRNA products.

Statutes affected:
Introduced: ()